Listen now | John McKendry, President and CEO of KYE, gives insights into the importance of operating within regulations, leadership in pharma, and new treatment and delivery options for ADHD.
S13 E01 Small Company, Seismic Impact: KYE Pharmaceuticals Redefines ADHD Treatment
S13 E01 Small Company, Seismic Impact: KYE…
S13 E01 Small Company, Seismic Impact: KYE Pharmaceuticals Redefines ADHD Treatment
Listen now | John McKendry, President and CEO of KYE, gives insights into the importance of operating within regulations, leadership in pharma, and new treatment and delivery options for ADHD.